Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity.

作者: Chung-Feng Hwang , Chih-Yen Chien , Shun-Cheng Huang , Yu-Fang Yin , Chao-Cheng Huang

DOI: 10.1002/PATH.2776

关键词:

摘要: Nasopharyngeal carcinoma (NPC) is known for its highly metastatic character. Recent advances in diagnosis and treatment have not improved the high mortality rate that attributable to early metastasis. Although several biomarkers correlate with metastasis prognosis, molecular mechanisms of NPC development progression remain unclear. We demonstrate comprehensively fibulin-3 down-regulated NPC. Loss expression significantly correlated advanced tumour lymph node-metastasis stages, indicates a poor 5-year survival rate. Functionally, has ability suppress cell migration invasion cancer cells by decreasing activity phospho-AKT. Conversely, depletion fibulin-3-mediated siRNAs may elevate phospho-AKT enhance migrate invade. Consistent this negative association between phospho-AKT, their levels are inversely specimens immunohistochemical analysis. Thus, lower an important indicator survival. It also contribute new therapeutic strategies block PI3K/AKT pathway cells.

参考文章(37)
J. K. C. Ho, C.-I. Wong, W.-Y. Chan, M.-M. Hsu, S.-M. Chuang, K.-W. Tzung, C.-T. Lin, Establishment and characterization of two nasopharyngeal carcinoma cell lines. Laboratory Investigation. ,vol. 62, pp. 713- 724 ,(1990)
Han-Chung Wu, Wannhsin Chen, Wing-Yee Chan, Huei-Ming Huang, Chun-Chi Wang, Mow-Ming Hsu, Sou-Ming Chuang, Chin-Tarng Lin, Characterization of seven newly established nasopharyngeal carcinoma cell lines. Laboratory Investigation. ,vol. 68, pp. 716- 727 ,(1993)
Satoshi Tanno, Sachie Tanno, Y Mitsuuchi, Deborah A Altomare, G H Xiao, Joseph R Testa, AKT Activation Up-Regulates Insulin-like Growth Factor I Receptor Expression and Promotes Invasiveness of Human Pancreatic Cancer Cells Cancer Research. ,vol. 61, pp. 589- 593 ,(2001)
Allan Hildesheim, Paul H. Levine, Etiology of Nasopharyngeal Carcinoma: A Review Epidemiologic Reviews. ,vol. 15, pp. 466- 485 ,(1993) , 10.1093/OXFORDJOURNALS.EPIREV.A036130
Ariane Sadr-Nabavi, Juliane Ramser, Juliane Volkmann, Joerg Naehrig, Frank Wiesmann, Beate Betz, Heide Hellebrand, Stefanie Engert, Susanne Seitz, Rene Kreutzfeld, Takako Sasaki, Norbert Arnold, Rita Schmutzler, Marion Kiechle, Dieter Niederacher, Nadia Harbeck, Edgar Dahl, Alfons Meindl, Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. International Journal of Cancer. ,vol. 124, pp. 1727- 1735 ,(2009) , 10.1002/IJC.24108
Mimi C. Yu, Jian-Min Yuan, Epidemiology of nasopharyngeal carcinoma. Seminars in Cancer Biology. ,vol. 12, pp. 421- 429 ,(2002) , 10.1016/S1044579X02000858
Chang-Han Chen, Jin-Mei Lai, Teh-Ying Chou, Cheng-Yu Chen, Li-Jen Su, Yuan-Chii Lee, Tai-Shan Cheng, Yi-Ren Hong, Chen-Kung Chou, Jacqueline Whang-Peng, Yu-Chung Wu, Chi-Ying F. Huang, VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway PLoS ONE. ,vol. 4, pp. e5052- ,(2009) , 10.1371/JOURNAL.PONE.0005052
R. Glaser, H. Y. Zhang, K. T. Yao, H. C. Zhu, F. X. Wang, G. Y. Li, D. S. Wen, Y. P. Li, Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 9524- 9528 ,(1989) , 10.1073/PNAS.86.23.9524
Nupur Bhattacharya, Antonio Sarno, Irina S. Idler, Marita Führer, Thorsten Zenz, Hartmut Döhner, Stephan Stilgenbauer, Daniel Mertens, High‐throughput detection of nuclear factor‐kappaB activity using a sensitive oligo‐based chemiluminescent enzyme‐linked immunosorbent assay International Journal of Cancer. ,vol. 127, pp. 404- 411 ,(2010) , 10.1002/IJC.25054
William M. Gallagher, Caroline A. Currid, Linda C. Whelan, Fibulins and cancer: friend or foe? Trends in Molecular Medicine. ,vol. 11, pp. 336- 340 ,(2005) , 10.1016/J.MOLMED.2005.06.001